Velarion Records
Free. Unsubscribe any time.

CRISPR Therapeutics AG (CRSP)

CRISPR Therapeutics AG filed 6 Form 4 statements naming a Rule 10b5-1 trading plan in the 2025 filing year, by 2 reporting owners, covering 13 transactions and 201,600 shares. 6 carry the SEC's AFF10B5ONE flag; 0 name a plan only in a footnote. No results print is on file in this window, so no interval is measured.

What stands out

Trades in CRISPR Therapeutics AG 13

Adoption dates in CRISPR Therapeutics AG 3

Results prints in CRISPR Therapeutics AG 0

Trades before a print in CRISPR Therapeutics AG 0

Interval to CRISPR Therapeutics AG’s next reported results date

How the interval and sources are counted →

Adoption dates CRISPR Therapeutics AG states

Filing text: “10b5-1 trading plan adopted by the reporting person on June 13, 2024”

Sources: SEC EDGAR full-text search and the SEC submissions API.